Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

<p>There was much discussion about current research in FAODs at our recent International Metabolic conference last month. Reneo Pharmaceuticals recently released positive results from the REN001 Phase1b LC-FAOD Study.</p>